IP Verse

Pentafarma competitive analysis

Loading summary...

Explore patent oppositions filed by Pentafarma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3078667	Formulation Of Boronic Acid Compounds	THE UNITED STATES OF AMERICA	Aug 19, 2019
EP2059232	Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaximin	ALFASIGMA	Jan 19, 2018
EP2477611	(Z)-2-Cyano-3-Hydroxy-But-2-Enoic Acid-(4'-Trifluormethylphenyl)-Amide Tablet Formulations With Improved Stability	SANOFI	Jan 4, 2018

Explore the latest publications and patents granted to Pentafarma, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Pentafarma, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Pentafarma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
PENTAFARMA SOCIEDADE TECNICO MEDICINAL	1	-	-	-
SANOFI	59	23	-	-
SANOFI AVENTIS DEUTSCHLAND	16	30	-	24